More...Snapshot
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
The global Capecitabine market size is estimated at xxx million USD with a CAGR xx% from
Table of Content
1 Industry Overview
1.1 Capecitabine Industry
Figure Capecitabine Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Capecitabine
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Capecitabine
1.2.2 Downstream
Table Application Segment of Capecitabine
Table